Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal-related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes
Differentiate with cutting-edge programs, attract new members, and boost revenue
Decision Support Tool: Features to Consider in Determining if a Clinical Trial is Phase II or Phase III
Once approved, youll begin treatment with a weekly injection regimen, guided by Dr
Lixisenatide therapy in older patients with type 2 diabetes inadequately controlled on their current antidiabetic treatment: the GetGoal-O randomized trial
Insulin sensitivity in De Novo Parkinsons disease: a hyperinsulinemic-Euglycemic clamp study